Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 ФГБОУ ВО «Омский государственный медицинский университет» Минздрава России, Омск, Россия; 2 Поликлиника №2 БУЗОО «ГКБ №1 им. А.Н. Кабанова», Омск, Россия dmitry_trukhan@mail.ru
Список исп. литературыСкрыть список 1. Лыткина И.Н., Малышев Н.А. Профилактика и лечение гриппа и острых респираторных вирусных инфекций среди эпидемиологически значимых групп населения. Клиническая инфектология и паразитология. 2015; 2 (13): 117–24. URL: https://www.elibrary.ru/item.asp?id=23849863 [Lytkina I.N., Malyshev N.A. Profilaktika i lechenie grippa i ostryh respiratornyh virusnyh infekcij sredi epidemiologicheski znachimyh grupp naseleniya. Klinicheskaya infektologiya i parazitologiya. 2015; 2 (13): 117–24. URL: https://www.elibrary.ru/item.asp?id= 23849863 (in Russian).] 2. Трухан Д.И., Филимонов С.Н. Дифференциальный диагноз основных пульмонологических симптомов и синдромов. СПб.: СпецЛит, 2019. URL: https://www.elibrary.ru/item.asp?id=41392166 [Truhan D.I., Filimonov S.N. Differencial'nyj diagnoz osnovnyh pul'monologicheskih simptomov i sindromov. Saint Petersburg: SpecLit, 2019. URL: https://www.elibrary.ru/item.asp?id=41392166 (in Russian).] 3. Трухан Д.И., Мазуров А.Л., Речапова Л.А. Острые респираторные вирусные инфекции: актуальные вопросы диагностики, профилактики и лечения в практике терапевта. Терапевтический архив. 2016; 11: 76–82. DOI: 10.17116/terarkh2016881176-82 [Truhan D.I., Mazurov A.L., Rechapova L.A. Ostrye respiratornye virusnye infekcii: aktual'nye voprosy diagnostiki, profilaktiki i lecheniya v praktike terapevta. Terapevticheskij arhiv. 2016; 11: 76–82. DOI: 10.17116/terarkh2016881176-82 (in Russian).] 4. Клинические рекомендации. Острые респираторные вирусные инфекции (ОРВИ) у взрослых. М., 2021. URL: https://cr.minzdrav.gov.ru/recomend/724_1 [Klinicheskie rekomendacii. Ostrye respiratornye virusnye infekcii (ORVI) u vzroslyh. Moscow, 2021. URL: https://cr.minzdrav.gov.ru/ recomend/724_1 (in Russian).] 5. Клинические рекомендации. Острая респираторная вирусная инфекция (ОРВИ). М., 2021. URL: https://cr.minzdrav.gov.ru/recomend/25_2 [Klinicheskie rekomendacii. Ostraya respiratornaya virusnaya infekciya (ORVI). Moscow, 2021. URL: https://cr.minzdrav.gov.ru/recomend/25_2 (in Russian).] 6. Гриневич В.Б., Губонина И.В., Дощицин В.Л. и др. Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный Консенсус 2020. Кардиоваскулярная терапия и профилактика. 2020; 19 (4): 2630. DOI: 10.15829/1728-8800-2020-2630 [Grinevich V.B., Gubonina I.V., Doshchicin V.L. et al. Osobennosti vedeniya komorbidnyh pacientov v period pandemii novoj koronavirusnoj infekcii (COVID-19). Nacional'nyj Konsensus 2020. Kardiovaskulyarnaya terapiya i profilaktika. 2020; 19 (4): 2630. DOI: 10.15829/1728-8800-2020-2630 (in Russian).] 7. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции COVID-19. Версия 16 (18.08.2022) утв. Минздравом России. URL: https://profilaktika.su/metodicheskie-rekomendatsii-po-koronavirusu-covid-19-ot-18-08-2022-versiya-16/ [Vremennye metodicheskie rekomendacii «Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii COVID-19. Versiya 16 (18.08.2022) utv. Minzdravom Rossii. URL: https://profilaktika.su/ metodicheskie-rekomendatsii-po-koronavirusu-covid-19-ot-18-08-2022-versiya-16/ (in Russian).] 8. Трухан Д.И., Давыдов Е.Л. Место и роль терапевта и врача общей практики в курации коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19): акцент на неспецифическую профилактику. Фарматека. 2021; 10: 34–45. DOI: 10.18565/pharmateca.2021.10.34-45 [Truhan D.I., Davydov E.L. Mesto i rol' terapevta i vracha obshchej praktiki v kuracii komorbidnyh pacientov v period pandemii novoj koronavirusnoj infekcii (COVID-19): akcent na nespecificheskuyu profilaktiku. Farmateka. 2021; 10: 34–45. DOI: 10.18565/pharmateca.2021.10.34-45 (in Russian).] 9. Трухан Д.И., Давыдов Е.Л., Чусова Н.А., Чусов И.С. Возможности терапевта в профилактике и на реабилитационном этапе после новой коронавирусной инфекции (COVID-19) коморбидных пациентов с артериальной гипертензией. Клинический разбор в общей медицине. 2021; 5: 6–15. DOI: 10.47407/kr2021.2.5.00064 [Truhan D.I., Davydov E.L., Chusova N.A., Chusov I.S. Vozmozhnosti terapevta v profilaktike i na reabilitacionnom etape posle novoj koronavirusnoj infekcii (COVID-19) komorbidnyh pacientov s arterial'noj gipertenziej. Clinical review for general practice. 2021; 5: 6–15. DOI: 10.47407/kr2021.2.5.00064 (in Russian).] 10. Трухан Д.И., Давыдов Е.Л., Чусова Н.А. Нутрицевтики в профилактике, лечении и на этапе реабилитации после новой коронавирусной инфекции (COVID-19). Клинический разбор в общей медицине. 2021; 7: 21–34. DOI: 10.47407/kr2021.2.7.00085 [Truhan D.I., Davydov E.L., CHusova N.A. Nutricevtiki v profilaktike, lechenii i na etape reabilitacii posle novoj koronavirusnoj infekcii (COVID-19). Clinical review for general practice. 2021; 7: 21–34. DOI: 10.47407/kr2021.2.7.00085 (in Russian).] 11. Трухан Д.И., Давыдов Е.Л. Место и роль терапевта и врача общей практики в курации коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19): акцент на реабилитационный этап. Фарматека. 2021; 13: 44–53. DOI: 10.18565/pharmateca.2021.13.44-53 [Truhan D.I., Davydov E.L. Mesto i rol' terapevta i vracha obshchej praktiki v kuracii komorbidnyh pacientov v period pandemii novoj koronavirusnoj infekcii (COVID-19): akcent na reabilitacionnyj etap. Farmateka. 2021; 13: 44–53. DOI: 10.18565/pharmateca.2021. 13.44-53 (in Russian).] 12. Трухан Д.И. Коморбидный пациент на терапевтическом приеме в период пандемии COVID-19. Актуальные аспекты реабилитационного периода. Фарматека. 2022;29(13):15–24. [Truhan D.I. Komorbidnyj pacient na terapevticheskom prieme v period pandemii COVID-19. Aktual'nye aspekty reabilitacionnogo perioda. Farmateka. 2022;29(13):15–24. (in Russian).] 13. Трухан Д.И., Иванова Д.С. Витаминно-минеральные комплексы в профилактике, лечении и на этапе реабилитации после острых респираторных вирусных инфекций и новой коронавирусной инфекции (COVID-19). Клинический разбор в общей медицине. 2022; 5: 33–46. Truhan D.I., Ivanova D.S. Vitaminno-mineral'nye kompleksy v profilaktike, lechenii i na etape reabilitacii posle ostryh respiratornyh virusnyh infekcij i novoj koronavirusnoj infekcii (COVID-19). Clinical review for general practice. 2022; 5: 33–46. [(in Russian).] 14. Calder PC, Carr AC, Gombart AF, Eggersdorfer M. Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients 2020; 12 (4): 1181. DOI: 10.3390/nu12041181 15. Alkhatib A. Antiviral Functional Foods and Exercise Lifestyle Prevention of Coronavirus. Nutrients 2020; 12 (9): 2633. DOI: 10.3390/nu12092633 16. Pecora F, Persico F, Argentiero A et al. The Role of Micronutrients in Support of the Immune Response against Viral Infections. Nutrients 2020; 12 (10): 3198. DOI: 10.3390/nu12103198 17. Jayawardena R, Sooriyaarachchi P, Chourdakis M et al. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes Metab Syndr 2020; 14 (4): 367–82. DOI: 10.1016/j.dsx.2020.04.015 18. Di Renzo L, Gualtieri P, Pivari F et al. COVID-19: Is there a role for immunonutrition in obese patient? J Transl Med 2020; 18 (1): 415. DOI: 10.1186/s12967-020-02594-4 19. Zelka FZ, Kocatürk RR, Özcan ÖÖ, Karahan M. Can Nutritional Supports Beneficial in Other Viral Diseases Be Favorable for COVID-19? Korean J Fam Med 2022; 43 (1): 3–15. DOI: 10.4082/kjfm.20.0134 20. Calder PC. Nutrition, immunity and COVID-19. BMJ Nutr Prev Health 2020; 3 (1): 74–92. DOI: 10.1136/bmjnph-2020-000085 21. Shakoor H, Feehan J, Al Dhaheri AS et al. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas 2021; 143: 1–9. DOI: 10.1016/j.maturitas.2020.08.003 22. Kumar P, Kumar M, Bedi O et al. Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology 2021; Jun 10: 1–16. DOI: 10.1007/s10787-021-00826-7 23. Galmés S, Serra F, Palou A. Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework. Nutrients 2020; 12 (9): 2738. DOI: 10.3390/nu12092738 24. Cámara M, Sánchez-Mata MC, Fernández-Ruiz V et al. L. A Review of the Role of Micronutrients and Bioactive Compounds on Immune System Supporting to Fight against the COVID-19 Disease. Foods 2021; 10 (5): 1088. DOI: 10.3390/foods10051088 25. Nedjimi B. Can trace element supplementations (Cu, Se, and Zn) enhance human immunity against COVID-19 and its new variants? Beni Suef Univ J Basic Appl Sci 2021; 10 (1): 33. DOI: 10.1186/s43088-021-00123-w 26. Yaseen MO, Jamshaid H, Saif A, Hussain T. mmunomodulatory role and potential utility of various nutrients and dietary components in SARS-CoV-2 infection. Int J Vitam Nutr Res 2022; 92 (1): 35–48. DOI: 10.1024/0300-9831/a000715 27. Grimble RF. Nutritional antioxidants and the modulation of inflammation: theory and practice. New Horiz 1994; 2 (2): 175–85. URL: https://pubmed.ncbi.nlm.nih.gov/7922442/ 28. Iddir M, Brito A, Dingeo G et al. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients 2020; 12 (6): 1562. DOI: 10.3390/nu12061562 29. Dharmalingam K, Birdi A, Tomo S et al. Trace Elements as Immunoregulators in SARS-CoV-2 and Other Viral Infections. Indian J Clin Biochem 2021; Feb 12: 1–11. DOI: 10.1007/s12291-021-00961-6 30. de Faria Coelho-Ravagnani C, Corgosinho FC, Sanches FFZ et al. Dietary recommendations during the COVID-19 pandemic. Nutr Rev 2021; 79 (4): 382–93. DOI: 10.1093/nutrit/nuaa067 31. Abioye AI, Bromage S, Fawzi W. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis. BMJ Glob Health 2021; 6 (1): e003176. DOI: 10.1136/bmjgh-2020-003176 32. Diyya ASM, Thomas NV. Multiple Micronutrient Supplementation: As a Supportive Therapy in the Treatment of COVID-19. Biomed Res Int 2022; 2022: 3323825. DOI: 10.1155/2022/3323825 33. Hemilä H, Douglas RM. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis 1999; 3 (9): 756–61. URL: https://pubmed.ncbi.nlm.nih.gov/10488881/ 34. Hemilä H. Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress. Int J Sports Med 1996; 17 (5): 379–83. DOI: 10.1055/s-2007-972864 35. Swain RA, Kaplan B. Upper respiratory infections: treatment selection for active patients. Phys Sportsmed 1998; 26 (2): 85–96. DOI: 10.3810/psm.1998.02.944 36. Khaw KT, Woodhouse P. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. BMJ 1995; 310 (6994): 1559–63. DOI: 10.1136/bmj.310.6994.1559 37. Shahbaz U, Fatima N, Basharat S et al. Role of vitamin C in preventing of COVID-19 infection, progression and severity. AIMS Microbiol 2022; 8 (1): 108–24. DOI: 10.3934/microbiol.2022010 38. Bae M, Kim H. Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19. Molecules 2020; 25 (22): 5346. DOI: 10.3390/molecules25225346 39. Ebrahimzadeh-Attari V, Panahi G, Hebert JR et al. Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals. Health Promot Perspect 2021; 11 (2): 119–36. DOI: 10.34172/hpp.2021.17 40. Abobaker A, Alzwi A, Alraied AHA. Overview of the possible role of vitamin C in management of COVID-19. Pharmacol Rep 2020; 72 (6): 1517–28. DOI: 10.1007/s43440-020-00176-1 41. Uddin MS, Millat MS, Baral PK et al. The protective role of vitamin C in the management of COVID-19: A Review. J Egypt Public Health Assoc 2021; 96 (1): 33. DOI: 10.1186/s42506-021-00095-w 42. Carr AC, Gombart AF. Multi-Level Immune Support by Vitamins C and D during the SARS-CoV-2 Pandemic. Nutrients 2022; 14 (3): 689. DOI: 10.3390/nu14030689 43. Holford P, Carr AC, Zawari M, Vizcaychipi MP. Vitamin C Intervention for Critical COVID-19: A Pragmatic Review of the Current Level of Evidence. Life (Basel) 2021; 11 (11): 1166. DOI: 10.3390/life11111166 44. Hiedra R, Lo KB, Elbashabsheh M et al. The use of IV vitamin C for patients with COVID-19: a case series. Expert Rev Anti Infect Ther 2020; 18 (12): 1259–61. DOI: 10.1080/14787210.2020.1794819 45. Olczak-Pruc M, Swieczkowski D, Ladny JR et al. Vitamin C Supplementation for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Nutrients 2022; 14 (19): 4217. DOI: 10.3390/ nu14194217 46. Vollbracht C, Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front Pharmacol 2022; 13: 899198. DOI: 10.3389/fphar.2022.899198 47. Firouzi S, Pahlavani N, Navashenaq JG et al. The effect of Vitamin C and Zn supplementation on the immune system and clinical outcomes in COVID-19 patients. Clin Nutr Open Sci 2022; 44: 144–54. DOI: 10.1016/j.nutos.2022.06.006 48. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection Am J Clin Nutr 1998; 68 (Suppl. 2): 447S–463S. DOI: 10.1093/ajcn/68.2.447S 49. Overbeck S, Rink L, Haase H. Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases. Arch Immunol Ther Exp (Warsz) 2008; 56 (1): 15–30. DOI: 10.1007/ s00005-008-0003-8 50. Kirkil G, Hamdi Muz M, Seçkin D et al. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease. Respir Med 2008; 102 (6): 840–4. DOI: 10.1016/j.rmed.2008.01.010 51. Samad N, Sodunke TE, Abubakar AR et al. The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic. J Inflamm Res 2021; 14: 527–50. DOI: 10.2147/JIR.S295377 52. Li J, Cao D, Huang Y et al. Zinc Intakes and Health Outcomes: An Umbrella Review. Front Nutr 2022; 9: 798078. DOI: 10.3389/fnut. 2022.798078 53. Vlieg-Boerstra B, de Jong N, Meyer R et al. Nutrient supplementation for prevention of viral respiratory tract infections in healthy subjects: A systematic review and meta-analysis. Allergy 2022; 77 (5): 1373–88. DOI: 10.1111/all.15136 54. Kaushik N, Subramani C, Anang S et al. Zinc salts block hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase. J Virol 2017; 91 (21): e00754-17. DOI: 10.1128/JVI.00754-17 55. Corrao S, Mallaci Bocchio R, Lo Monaco M et al. Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc. Nutrients 2021; 13 (4): 1261. DOI: 10.3390/nu13041261 56. Patel O, Chinni V, El-Khoury J et al. A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients. J Med Virol 2021; 93 (5): 3261–7. 57. Scarpellini E, Balsiger LM, Maurizi V et al. Zinc and gut microbiota in health and gastrointestinal disease under the COVID-19 suggestion. Biofactors 2022; 48 (2): 294–306. DOI: 10.1002/biof.1829 58. Skalny AV, Rink L, Ajsuvakova OP et al. Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). Int J Mol Med 2020; 46 (1): 17–26. DOI: 10.3892/ijmm.2020.4575 59. Han YS, Chang GG, Juo CG et al. Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. Biochemistry 2005; 44 (30): 10349–59. DOI: 10.1021/bi0504761 60. Jothimani D, Kailasam E, Danielraj S et al. COVID-19: Poor outcomes in patients with zinc deficiency. Int J Infect Dis 2020; 100: 343–9. DOI: 10.1016/j.ijid.2020.09.014 61. Wessels I, Rolles B, Rink L. The Potential Impact of Zinc Supplementation on COVID-19. Pathogenesis. Front Immunol 2020; 11: 1712. DOI: 10.3389/fimmu.2020.01712 62. Wessels I, Rolles B, Slusarenko AJ, Rink L. Zinc deficiency as a possible risk factor for increased susceptibility and severe progression of Corona Virus Disease 19. Br J Nutr 2022; 127 (2): 214–32. DOI: 10.1017/S0007114521000738 63. Tabatabaeizadeh SA. Zinc supplementation and COVID-19 mortality: a meta-analysis. Eur J Med Res 2022; 27 (1): 70. DOI: 10.1186/s40001-022-00694-z 64. Rahman MT, Idid SZ. Can Zn Be a Critical Element in COVID-19 Treatment? Biol Trace Elem Res 2021; 199 (2): 550–8. DOI: 10.1007/s12011-020-02194-9 65. de Almeida Brasiel PG. The key role of zinc in elderly immunity: A possible approach in the COVID-19 crisis. Clin Nutr ESPEN 2020; 38: 65–6. DOI: 10.1016/j.clnesp.2020.06.003 66. Hunter J, Arentz S, Goldenberg J et al. S. Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials. BMJ Open 2021; 11 (11): e047474. DOI: 10.1136/bmjopen-2020-047474 67. Marreiro DDN, Cruz KJC, Oliveira ARS et al. Antiviral and immunological activity of zinc and possible role in COVID-19. Br J Nutr 2022; 127 (8): 1172–9. DOI: 10.1017/S0007114521002099 68. Martinez SS, Huang Y, Acuna L et al. Role of Selenium in Viral Infections with a Major Focus on SARS-CoV-2. Int J Mol Sci 2021; 23 (1): 280. DOI: 10.3390/ijms23010280 69. Barchielli G, Capperucci A, Tanini D. The Role of Selenium in Pathologies: An Updated Review. Antioxidants (Basel) 2022; 11 (2): 251. DOI: 10.3390/antiox11020251 70. Moghaddam A, Heller RA, Sun Q et al. Selenium Deficiency Is Associated with Mortality Risk from COVID-19. Nutrients 2020; 12 (7): 2098. DOI: 10.3390/nu12072098 71. Bermano G, Méplan C, Mercer DK, Hesketh JE. Selenium and viral infection: are there lessons for COVID-19? Br J Nutr 2021; 125 (6): 618–27. DOI: 10.1017/S0007114520003128 72. Tomo S, Saikiran G, Banerjee M, Paul S. Selenium to selenoproteins – role in COVID-19. EXCLI J 2021; 20: 781–91. DOI: 10.17179/excli2021-3530 73. Schomburg L. Selenium Deficiency in COVID-19-A Possible Long-Lasting Toxic Relationship. Nutrients 2022; 14 (2): 283. DOI: 10.3390/nu14020283 74. Schomburg L. Selenoprotein P – Selenium transport protein, enzyme and biomarker of selenium status. Free Radic Biol Med 2022; 191: 150–63. DOI: 10.1016/j.freeradbiomed.2022.08.022 75. Lima LW, Nardi S, Santoro V, Schiavon M. The Relevance of Plant-Derived Se Compounds to Human Health in the SARS-CoV-2 (COVID-19) Pandemic Era. Antioxidants (Basel) 2021; 10 (7): 1031. DOI: 10.3390/antiox10071031 76. Im JH, Je YS, Baek J et al. Nutritional status of patients with COVID-19. Int J Infect Dis 2020; 100: 390–3. DOI: 10.1016/j.ijid. 2020.08.018 77. Younesian O, Khodabakhshi B, Abdolahi N et al. Decreased Serum Selenium Levels of COVID-19 Patients in Comparison with Healthy Individuals. Biol Trace Elem Res 2021; Jul 1: 1–6. DOI: 10.1007/s12011-021-02797-w 78. Skesters A, Kustovs D, Lece A et al. Selenium, selenoprotein P, and oxidative stress levels in SARS-CoV-2 patients during illness and recovery. Inflammopharmacology 2022; 30 (2): 499–503. DOI: 10.1007/s10787-022-00925-z 79. Oliveira CR, Viana ET, Gonçalves TF et al. Therapeutic use of intravenous selenium in respiratory and immunological diseases: evidence based on reviews focused on clinical trials. Adv Respir Med 2022; Jan 31. DOI: 10.5603/ARM.a2022.0018 80. Rayman MP, Taylor EW, Zhang J. The relevance of selenium to viral disease with special reference to SARS-CoV-2 and COVID-19. Proc Nutr Soc 2022; Aug 19: 1–12. DOI: 10.1017/S0029665122002646 81. Kieliszek M, Lipinski B. Selenium supplementation in the prevention of coronavirus infections (COVID-19). Med Hypotheses 2020; 143: 109878. DOI: 10.1016/j.mehy.2020.109878 82. Liu X, Yin S, Li G. Effects of selenium supplement on acute lower respiratory tract infection caused by respiratory syncytial virus. Zhonghua Yu Fang Yi Xue Za Zhi 1997; 31 (6): 358–61. URL: https://pubmed.ncbi.nlm.nih.gov/9863072/ 83. Taheri S, Asadi S, Nilashi M et al. A literature review on beneficial role of vitamins and trace elements: Evidence from published clinical studies. J Trace Elem Med Biol 2021; 67: 126789. DOI: 10.1016/j.jtemb.2021.126789. 84. Junaid K, Ejaz H, Abdalla AE et al. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients 2020; 12 (10): 2992. DOI: 10.3390/nu12102992 85. Nedjimi B. Can trace element supplementations (Cu, Se, and Zn) enhance human immunity against COVID-19 and its new variants? Beni Suef Univ J Basic Appl Sci 2021; 10 (1): 33. DOI: 10.1186/ s43088-021-00123-w 86. Engin AB, Engin ED, Engin A. Can iron, zinc, copper and selenium status be a prognostic determinant in COVID-19 patients? Environ Toxicol Pharmacol 2022; 95: 103937. DOI: 10.1016/j.etap.2022.103937 87. Alexander J, Tinkov A, Strand TA et al. Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19. Nutrients 2020; 12 (8): 2358. DOI: 10.3390/nu12082358 88. Балаболкин И.И., Булгакова В.А., Ушакова В.В. Современное состояние проблемы часто болеющих детей. Педиатрическая фармакология. 2007; 2: 48–52. URL: https://www.elibrary.ru/ item.asp? id=11611211 [Balabolkin I.I., Bulgakova V.A., Ushakova V.V. Sovremennoe sostoyanie problemy chasto boleyushchih detej. Pediatricheskaya farmakologiya. 2007; 2: 48–52. URL: https://www.elibrary.ru/item. asp?id=11611211 (in Russian).] 89. Трухан Д.И, Тарасова Л.В. Особенности клиники и лечения острых респираторных вирусных инфекций в практике врача-терапевта. Врач. 2014; 8: 44–7. URL: https://www.elibrary.ru/item. asp?id=21905156 [Truhan D.I, Tarasova L.V. Osobennosti kliniki i lecheniya ostryh respiratornyh virusnyh infekcij v praktike vracha-terapevta. Vrach. 2014; 8: 44–7. URL: https://www.elibrary.ru/item.asp?id=21905156 (in Russian).] 90. Трухан ДИ, Мазуров АЛ, Речапова ЛА. Острые респираторные вирусные инфекции: актуальные вопросы диагностики, профилактики и лечения в практике терапевта. Терапевтический архив. 2016; 11: 76–82. DOI: 10.17116/terarkh2016881176-82 [Truhan DI, Mazurov AL, Rechapova LA. Ostrye respiratornye virusnye infekcii: aktual'nye voprosy diagnostiki, profilaktiki i lecheniya v praktike terapevta. Terapevticheskij arhiv. 2016; 11: 76–82. DOI: 10.17116/terarkh2016881176-82 (in Russian).]